Introduction
============

Liver cancer is the third most common cause of cancer-associated mortality worldwide, accounting for an estimated 9.2% of total cancer-associated mortalities in 2008 ([@b1-ol-0-0-4853]). Surgery is considered the most effective treatment for patients with hepatocellular carcinoma (HCC) ([@b2-ol-0-0-4853]); however, the indications for surgery are restricted by the size and total number of tumors ([@b2-ol-0-0-4853],[@b3-ol-0-0-4853]). Although the 5-year survival rate of patients with HCC has improved by \>30% over the past decade, the recurrence rate following surgery is estimated to be nearly 50% ([@b4-ol-0-0-4853]); therefore, systemic chemotherapy is required for patients with advanced stages of HCC, in order to prolong their survival.

MicroRNAs (miRNAs) are endogenous non-coding RNAs of 18--22 nucleotides in length ([@b3-ol-0-0-4853],[@b5-ol-0-0-4853]). The effect of miRNAs on the regulation of the expression of various genes is so broad that one miRNA controls \>200 genes ([@b6-ol-0-0-4853]). Aberrant expression of miRNAs is a common feature among various types of human cancer, and has been reportedly associated with patient survival ([@b7-ol-0-0-4853]--[@b10-ol-0-0-4853]). Regarding the correlation between miRNAs and HCC, several studies have detected the aberrant expression of specific miRNAs in HCC tissues when compared with normal tissues ([@b11-ol-0-0-4853]--[@b14-ol-0-0-4853]). These studies indicated that the modulation of non-coding RNAs, particularly miRNAs, may be a valuable therapeutic target in HCC.

The aim of the present study was to elucidate the miRNA profiles that are associated with differentiation and hepatitis B virus (HBV) infection observed in HCC cell lines. The characterization of miRNA expression patterns using various parameters may be a novel approach for the treatment of patients with HCC.

Materials and methods
=====================

### Cell lines and culture

The Alex, Hep3B, HepG2, HuH1, HuH7, JHH1, JHH2, JHH5, JHH6, HLE, HLF and Li-7 HCC cell lines were obtained from the Japanese Cancer Research Resources Bank (Tokyo, Japan) and transported to our laboratory. The cell lines were authenticated by the cell bank using short tandem repeat polymerase chain reaction. The cells were grown in minimal essential medium (Gibco; Thermo Fisher Scientific Inc., Waltham, MA, USA) supplemented with 10% fetal bovine serum (catalog no., 533-69545; Wako Pure Chemical Industries, Tokyo, Japan) and penicillin (10,000 units/ml)-streptomycin (10,000 µg/ml) (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA) in a humidified atmosphere of 5% CO~2~ at 37°C.

### Analysis of microRNA array

Total RNA was extracted from the cancer cell lines using a miRNeasy Mini kit (Qiagen, Hilden, Germany), according to the manufacturer\'s instructions. RNA samples typically showed A~260~/~280~ ratios between 1.9 and 2.1 on an Agilent 2,100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA).

Following the measurement of the RNA using an RNA 6,000 Nano kit (Agilent Technologies, Tokyo, Japan), the samples were labeled using a miRCURY Hy3/Hy5 Power Labeling kit (Takara Bio Inc., Tokyo, Japan) and hybridized onto a human miRNA Oligo chip (version 19.0; Toray Industries, Inc., Tokyo, Japan). Scanning was conducted with the 3D-Gene Scanner 3,000 (Toray Industries, Inc., Kusatsu, Japan). 3D-Gene extraction software version 1.2 (Toray Industries, Inc.) was used to read the raw intensity of the image. To determine the change in miRNA expression between poorly- and well-differentiated HCC cell lines or HBV-positive and HBV-negative HCC cell lines, the raw data were analyzed using GeneSpringGX version 10.0 (Agilent Technologies). Samples were first normalized to the 28S RNA and the baseline was then corrected to the median of all samples.

Replicate data were analyzed following their classification into: i) Poorly- and well-differentiated human HCC cells, and ii) HBV-positive and -negative human HCC cells, which were organized by the hierarchical clustering in the GeneSpring software. For the log~2~ ratios of the miRNA expression intensity between two groups, hierarchical clustering was performed using the furthest neighbor method with the absolute Pearson\'s correlation coefficient as a metric. The log~2~ ratios were median-centered across each miRNA in a color-coding of the heat map. The P-value cutoff was set to 0.05. Only changes of \>50% in at least one of the time points for each sample were considered significant. All of the analyzed data were scaled by global normalization.

### Statistical analysis

All analyses were conducted using the JMP 8.0 software (SAS Institute, Inc., Cary, NC, USA). A paired analysis between the groups was conducted using a Student\'s t test. P\<0.05 was used to indicate statistically significant differences between the groups.

Results
=======

### Differences in miRNA expression between poorly- and well-differentiated human HCC cell lines

Using a custom microarray platform, the expression levels of 1,719 miRNAs were analyzed in various human HCC cell lines. As shown in [Fig. 1](#f1-ol-0-0-4853){ref-type="fig"} and [Tables I](#tI-ol-0-0-4853){ref-type="table"} and [II](#tII-ol-0-0-4853){ref-type="table"}, of the 1,719 miRNAs, 4 were found to be significantly upregulated and 52 were significantly downregulated in the poorly-differentiated cells, as compared with the well-differentiated cells. Unsupervised hierarchical clustering analysis with Pearson\'s correlation showed that the poorly-differentiated HCC cell lines clustered both together and separately from the well-differentiated HCC cells ([Fig. 1](#f1-ol-0-0-4853){ref-type="fig"}).

### Differences in miRNA expression between HBV-positive and HBV-negative HCC lines

To examine the effect of HBV infection on alterations in miRNAs, miRNA profiles were analyzed in HBV-positive and -negative human HCC cell lines. As shown in [Fig. 2](#f2-ol-0-0-4853){ref-type="fig"} and [Tables III](#tIII-ol-0-0-4853){ref-type="table"} and [IV](#tIV-ol-0-0-4853){ref-type="table"}, of the 1,719 miRNAs, 125 miRNAs were found to be significantly upregulated and 2 were significantly downregulated in the HBV-positive HCC cells, as compared with the HBV-negative HCC cells. Unsupervised hierarchical clustering analysis with Pearson\'s correlation showed that the HBV-positive HCC cell lines clustered both together and separately from the HBV-negative HCC cells ([Fig. 2](#f2-ol-0-0-4853){ref-type="fig"}).

Discussion
==========

The aim of the present study was to elucidate the targetable miRNAs associated with the etiology, diagnosis and treatment of HCC. Certain miRNAs, such as miR-26b and miR-132, were found to be downregulated in poorly-differentiated HCC. It has recently been reported that dedifferentiation is involved in the epithelial-mesenchymal transition (EMT), and particularly in the EMT of cancer ([@b15-ol-0-0-4853]). In order to invade and metastasize to different organs, cancer cells shed their differentiated epithelial phenotype through EMT ([@b15-ol-0-0-4853]), which suggests that miR-26b or miR-132 may be associated with cancer invasion and metastasis via EMT. In addition, miR-26b has been shown to directly suppress the expression of CDK6 and cyclin E1, resulting in reduced retinoblastoma-associated protein phosphorylation and inhibited cell proliferation ([@b16-ol-0-0-4853]). miR-132 also inhibits tumor cell proliferation, invasion and migration by targeting Sox5 ([@b17-ol-0-0-4853]). These studies also indicated that miR-26b and miR-132 may directly inhibit cancer invasion and metastasis.

In the present study, miR-4476 was upregulated in poorly-differentiated carcinoma. Recently, it has been demonstrated that miR-4476 is one of the top 10 validated miRNA markers differentiating pancreatobiliary cancer from other clinical conditions, including other types of cancer and healthy controls ([@b18-ol-0-0-4853]). Therefore, this result suggests that advanced stages of HCC, which includes poorly-differentiated cells, induce cholestasis in a similar fashion to pancreatobiliary cancers and may increase the miR-4476 upregulation.

Regarding the effect of HBV, miR-99b was found to be upregulated in HBV-infected HCC cells in the present study. It has been reported that the expression of miR-99b is associated with the presence of lymph node metastasis ([@b19-ol-0-0-4853]). In addition, certain miRNAs are associated with the oncogenic processes of HBV-related HCC ([@b3-ol-0-0-4853]). This data indicates that miRNAs play an important role in the etiology of HBV-related HCC.

In addition, Wang *et al* ([@b20-ol-0-0-4853]) demonstrated that 10 upregulated miRNAs (miR-217, miR-518b, miR-517c, miR-520g, miR-519a, miR-522, miR-518e, miR-525-3p, miR-512-3p, and miR-518a-3p) and 11 downregulated miRNAs (miR-138, miR-214, miR-214, miR-199a-5p, miR-433, miR-511, miR-592, miR-483-5p, miR-483-3p, miRNA-708 and miRNA-1275) were identified in HBV-associated HCC tissues. In the present study, the same microRNAs were not detected in HBV-positive HCC cells; therefore, adjacent normal tissues may be included in the human HCC tissues. These results indicate that the microRNA expression patterns are different from cancer cell lines and cancer tissues. Cell-cell interaction may affect microRNA expression in the microenvironment of cancer tissues.

In conclusion, changes in the regulation of key miRNAs due to differentiation and HBV infection were observed in human HCC cell lines. The present findings suggested that differences in miRNA expression may serve as a novel marker that can aid in elucidating the etiology of human HCC and assist in designing treatments.

miR/miRNA

:   microRNA

HBV

:   hepatitis virus B

HCC

:   hepatacellular carcinoma

![Hierarchical clustering of miRNAs in poorly- and well-differentiated human HCC cell lines. Clustering was performed according to the expression profiles of 56 differentially-expressed miRNAs in poorly- and well-differentiated human HCC cell lines. The columns represent the analyzed samples, while the rows represent the miRNAs. The miRNA clustering tree is shown on the left and the sample clustering tree appears at the top. The color scale shown at the top illustrates the relative expression level of the miRNAs, with red indicating a high expression level and blue indicating a low expression level. miR/miRNA, microRNA; HCC, hepatocellular carcinoma.](ol-12-03-1687-g00){#f1-ol-0-0-4853}
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###### 

Upregulated expression of miRNA in poorly-differentiated HCC cells, as compared with well-differentiated HCC cells.

  Upregulated miRNAs   P-values      PD/WD
  -------------------- ------------- -------------
  hsa-miR-4498         0.026931863   2.867818244
  hsa-miR-6842-5p      0.025697328   2.461117562
  hsa-miR-6800-5p      0.012943201   1.941309698
  hsa-miR-4476         0.030699533   1.759074121

HCC, hepatocellular carcinoma; PD, poorly-differentiated; WD, well-differentiated; miR/miRNA, microRNA.

###### 

miRNA downregulation in poorly-differentiated HCC cells as compared with well-differentiated HCC cells.

  Downregulated miRNAs   P-value       PD/WD
  ---------------------- ------------- -------------
  hsa-miR-3178           0.000974376   0.348146401
  hsa-miR-1469           0.001067111   0.256078680
  hsa-miR-6805-3p        0.001867476   0.415970562
  hsa-miR-3195           0.001905223   0.508164983
  hsa-miR-4497           0.002391438   0.540368285
  hsa-miR-4532           0.003797834   0.570642150
  hsa-miR-4745-5p        0.005612978   0.355402751
  hsa-miR-6516-3p        0.008665895   0.446770518
  hsa-miR-4634           0.009685127   0.572465267
  hsa-miR-8059           0.010182045   0.344828448
  hsa-miR-3940-5p        0.010700356   0.359070586
  hsa-miR-1909-3p        0.011248665   0.401354333
  hsa-miR-6795-5p        0.013039021   0.381096482
  hsa-miR-132-3p\*       0.014002236   0.500476019
  hsa-miR-26b-5p\*       0.014113042   0.357904962
  hsa-miR-6765-5p        0.014456214   0.375871481
  hsa-miR-4516           0.015208421   0.529129777
  hsa-miR-1268a          0.015252062   0.430113531
  hsa-miR-1225-3p        0.015675303   0.690060509
  hsa-miR-191-5p         0.017084147   0.504203776
  hsa-miR-5787           0.019066417   0.426932073
  hsa-miR-3665           0.019620817   0.372159995
  hsa-miR-6784-5p        0.021959677   0.423492063
  hsa-miR-762            0.022064969   0.428794025
  hsa-miR-425-5p         0.022167838   0.469352798
  hsa-miR-6076           0.02338926    0.489615399
  hsa-miR-4284           0.025395945   0.607050985
  hsa-miR-6816-5p        0.025658929   0.342345756
  hsa-miR-6756-5p        0.026680935   0.418869876
  hsa-miR-6765-3p        0.028318318   0.681942211
  hsa-miR-1343-3p        0.029279009   0.369035375
  hsa-miR-4697-5p        0.029348892   0.356689006
  hsa-miR-4286           0.029548705   0.606212249
  hsa-miR-3656           0.029629729   0.441205506
  hsa-miR-6869-5p        0.030683568   0.450864492
  hsa-miR-455-3p         0.031351866   0.340391294
  hsa-miR-933            0.032763996   0.446918418
  hsa-miR-3937           0.032949412   0.428511322
  hsa-miR-663b           0.033189114   0.645740828
  hsa-miR-1228-5p        0.034737307   0.468155726
  hsa-miR-4508           0.035873986   0.465234100
  hsa-miR-23c            0.038312747   0.398936550
  hsa-miR-642b-3p        0.03853801    0.474336719
  hsa-miR-4530           0.03858166    0.564198369
  hsa-miR-4271           0.039079038   0.375946014
  hsa-miR-18b-5p         0.046265132   0.239201813
  hsa-miR-663a           0.046711854   0.497938251
  hsa-miR-7704           0.046961909   0.562374269
  hsa-miR-6826-5p        0.048141645   0.450205273
  hsa-miR-3651           0.048451237   0.591375188
  hsa-miR-423-3p         0.04891406    0.585477071
  hsa-miR-128-2-5p       0.049142734   0.487264349

HCC, hepatocellular carcinoma; miR/miRNA, microRNA; PD, poorly-differentiated; WD, well-differentiated.

###### 

miRNA upregulation in HBV-positive HCC cells as compared with HBV-negative HCC cells.

  Upregulated miRNAs   P-value       HBV(+)/HBV(−)
  -------------------- ------------- ---------------
  hsa-miR-99b-5p       0.000000648   9.941304892
  hsa-miR-181a-5p      0.033034307   6.386379599
  hsa-miR-96-5p        0.021545231   4.758785302
  hsa-miR-1237-3p      0.037257957   4.456964302
  hsa-miR-182-5p       0.000177429   4.362818593
  hsa-miR-125a-5p      0.005613398   3.719262548
  hsa-miR-99a-3p       0.045954557   3.494856992
  hsa-miR-6861-5p      0.008595301   3.308580171
  hsa-miR-6726-5p      0.002146572   3.247738683
  hsa-miR-4763-3p      0.003813145   3.075732768
  hsa-miR-192-5p       0.018546977   3.068893554
  hsa-miR-194-5p       0.027213074   3.058433608
  hsa-miR-324-5p       0.047875781   3.025508821
  hsa-miR-3665         0.000663551   3.021045838
  hsa-miR-6848-5p      0.013784248   3.003340126
  hsa-miR-658          0.002645683   2.977949153
  hsa-miR-3652         0.006332146   2.969527506
  hsa-miR-744-5p       0.00486586    2.967774559
  hsa-miR-6132         0.00428827    2.930151490
  hsa-miR-26b-5p       0.001262254   2.924882610
  hsa-miR-6872-3p      0.013248885   2.880715544
  hsa-miR-6813-5p      0.008803711   2.879469305
  hsa-miR-4289         0.001809926   2.859805967
  hsa-miR-3620-5p      0.004247363   2.837639155
  hsa-miR-6779-5p      0.007205138   2.789908382
  hsa-miR-6799-5p      0.006060554   2.738799039
  hsa-miR-1587         0.005536711   2.737246496
  hsa-miR-23c          0.007181466   2.716255574
  hsa-miR-4725-3p      0.026222737   2.713962628
  hsa-miR-1343-3p      0.029279009   2.709767325
  hsa-miR-937-5p       0.016562749   2.704056512
  hsa-miR-22-5p        0.012966623   2.690740441
  hsa-miR-6816-5p      0.01716898    2.690475807
  hsa-miR-6781-5p      0.043635552   2.662786094
  hsa-miR-6768-5p      0.009273849   2.658821540
  hsa-miR-331-3p       0.001849624   2.656822543
  hsa-miR-4327         0.021811096   2.620193911
  hsa-miR-6727-5p      0.006674229   2.597922456
  hsa-miR-6722-3p      0.024746989   2.593107400
  hsa-miR-5787         0.001467763   2.579963522
  hsa-miR-29c-3p       0.016910541   2.559268566
  hsa-miR-22-3p        0.000110838   2.545731351
  hsa-miR-3654         0.007328507   2.536585596
  hsa-miR-4507         0.013990723   2.509463513
  hsa-miR-4492         0.005952616   2.502548594
  hsa-miR-4741         0.009337902   2.486124356
  hsa-miR-3621         0.015640016   2.485247656
  hsa-miR-4734         0.018933717   2.483317331
  hsa-miR-6085         0.014443652   2.479844683
  hsa-miR-361-5p       0.000442472   2.474136455
  hsa-miR-5001-5p      0.017579881   2.466921307
  hsa-miR-6845-5p      0.018960866   2.444791599
  hsa-miR-4651         0.031451007   2.433852833
  hsa-miR-664a-3p      0.022326221   2.417433070
  hsa-miR-6850-5p      0.043000995   2.410122248
  hsa-miR-3940-5p      0.016650066   2.406661676
  hsa-miR-4750-3p      0.034041218   2.405803427
  hsa-miR-4716-5p      0.026554669   2.368757616
  hsa-miR-365a, b-3p   0.002715735   2.366494444
  hsa-miR-4508         0.007102476   2.352557384
  hsa-miR-191-5p       0.000120655   2.346171925
  hsa-miR-6731-5p      0.024175847   2.333212883
  hsa-miR-6822-5p      0.001204907   2.331567699
  hsa-miR-4745-5p      0.015938518   2.330093060
  hsa-miR-1469         0.039665847   2.329351564
  hsa-miR-762          0.010944843   2.327308371
  hsa-miR-4505         0.021004934   2.322786379
  hsa-miR-3656         0.012652065   2.316840605
  hsa-miR-374c-5p      0.046201574   2.309229277
  hsa-miR-4306         0.048384309   2.306213437
  hsa-miR-4463         0.043512115   2.274070423
  hsa-miR-6749-5p      0.034695635   2.258437039
  hsa-miR-425-5p       0.005354369   2.258230321
  hsa-miR-1909-3p      0.015268122   2.256696389
  hsa-miR-4443         0.002035551   2.247501172
  hsa-miR-6784-5p      0.020580101   2.233472310
  hsa-miR-6791-5p      0.025022751   2.227203891
  hsa-miR-6765-5p      0.03907315    2.196934984
  hsa-miR-4695-3p      0.049035558   2.196882473
  hsa-miR-4731-5p      0.026948571   2.153748402
  hsa-miR-324-3p       0.008210293   2.148721766
  hsa-miR-7977         0.000154283   2.145089801
  hsa-miR-3178         0.022352      2.127295883
  hsa-miR-642b-3p      0.020856928   2.086744300
  hsa-miR-6786-5p      0.044762899   2.078505858
  hsa-miR-6869-5p      0.038412235   2.071725430
  hsa-miR-663a         0.030021104   2.045834444
  hsa-miR-4488         0.028003788   2.038574665
  hsa-miR-7114-5p      0.007743122   2.030825064
  hsa-miR-3180-3p      0.025916357   2.023796991
  hsa-miR-6125         0.032086556   2.008344893
  hsa-miR-21-5p        0.049645958   2.003677073
  hsa-miR-125a-3p      0.011495522   1.999755015
  hsa-miR-4632-5p      0.009562923   1.999301680
  hsa-miR-132-3p       0.014002236   1.998097736
  hsa-miR-23b-3p       0.022475719   1.997567414
  hsa-miR-27b-3p       0.042591151   1.976679667
  hsa-miR-6515-3p      0.043906577   1.956257303
  hsa-miR-6803-5p      0.046392317   1.928556399
  hsa-miR-6724-5p      0.044214734   1.926601244
  hsa-miR-4286         0.000877998   1.922172274
  hsa-miR-660-5p       0.029655234   1.920831210
  hsa-miR-23a-3p       0.039960215   1.913813878
  hsa-miR-1273g-3p     0.008489419   1.887689346
  hsa-miR-6076         0.046682307   1.869956757
  hsa-miR-3184-5p      0.002114973   1.859834906
  hsa-miR-24-3p        0.014737629   1.853159621
  hsa-miR-1224-3p      0.024802116   1.852687602
  hsa-miR-128-3p       0.034442661   1.852193951
  hsa-miR-5739         0.015007524   1.813507960
  hsa-miR-6766-3p      0.015357929   1.810550072
  hsa-miR-6089         0.01949948    1.777100276
  hsa-miR-4530         0.045923322   1.741259423
  hsa-miR-4497         0.010048462   1.733250168
  hsa-miR-4634         0.011175767   1.733040523
  hsa-miR-3195         0.048689395   1.633334528
  hsa-miR-4532         0.036380915   1.573156813
  hsa-miR-6765-3p      0.008380175   1.570194232
  hsa-miR-3648         0.018858947   1.557642234
  hsa-miR-4723-5p      0.013307402   1.556739349
  hsa-miR-1260a        0.009160577   1.550976854
  hsa-miR-7641         0.040903303   1.528537769
  hsa-miR-7975         0.033849532   1.527016010
  hsa-miR-1260b        0.037598062   1.399160141
  hsa-miR-4454         0.044853364   1.361601255

HCC, hepatocellular carcinoma; miR/miRNA, microRNA; HBV, hepatitis B virus.

###### 

miRNA downregulation in HBV-positive HCC cells as compared with HBV-negative HCC cells.

  Downregulated miRNAs   P-value       HBV(+)/HBV(−)
  ---------------------- ------------- ---------------
  hsa-miR-146b-5p        0.012478369   0.125399188
  hsa-miR-3622a-5p       0.025065220   0.861532186

miR/miRNA, microRNA; HCC, hepatocellular carcinoma; HBV, hepatitis B virus.
